uniQure (QURE) is down -50.2%, or -$33.98 to $33.71.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QURE:
- FDA’s ‘surprising’ uniQure reversal drags down Biohaven
- Optimistic Buy Rating for uniQure Amid Promising AMT-130 Data and Regulatory Prospects
- FDA’s uniQure reversal unlikely to impact Regenxbio’s programs, says Stifel
- uniQure falls -57.2%
- Biohaven comparison to uniQure may not be applicable, says Citi